Nitrofurantoin: Targeted Urinary Tract Infection Relief
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 100 | $0.59 | $59.34 (0%) | 🛒 Add to cart |
| 200 | $0.50 | $118.68 $100.62 (15%) | 🛒 Add to cart |
| 300 | $0.47 | $178.02 $141.04 (21%) | 🛒 Add to cart |
| 400 | $0.45 | $237.36 $180.60 (24%) | 🛒 Add to cart |
| 500 | $0.44
Best per pill | $296.70 $221.02 (26%) | 🛒 Add to cart |
| 600 | $0.44 | $356.04 $265.74 (25%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 100 | $0.50 | $49.88 (0%) | 🛒 Add to cart |
| 200 | $0.42 | $99.76 $83.42 (16%) | 🛒 Add to cart |
| 300 | $0.39 | $149.64 $117.82 (21%) | 🛒 Add to cart |
| 400 | $0.38 | $199.52 $153.08 (23%) | 🛒 Add to cart |
| 500 | $0.37 | $249.40 $187.48 (25%) | 🛒 Add to cart |
| 600 | $0.37
Best per pill | $299.28 $219.30 (27%) | 🛒 Add to cart |
Synonyms
| |||
Nitrofurantoin is a prescription antibacterial medication specifically indicated for the treatment and prophylaxis of uncomplicated urinary tract infections (UTIs) caused by susceptible strains of Escherichia coli, Enterococcus faecalis, Staphylococcus aureus, certain strains of Klebsiella and Enterobacter species. It belongs to the nitrofuran antibiotic class and functions as a bactericidal agent by interfering with multiple bacterial enzyme systems, thereby inhibiting vital biochemical processes including acetylcoenzyme A, DNA, RNA, and cell wall synthesis. Its unique pharmacokinetic profile results in high concentrations in the urine and renal tissues, with minimal systemic absorption, making it an ideal choice for targeting pathogens within the urinary tract while limiting broader impact on the body’s microbiome.
Features
- Contains the active pharmaceutical ingredient nitrofurantoin in either macrocrystalline or monohydrate/macrocrystal form.
- Available in oral formulations: capsules (25 mg, 50 mg, 100 mg) and an oral suspension.
- Exhibits bactericidal activity against a spectrum of Gram-positive and Gram-negative uropathogens.
- Features a unique mechanism of action, reducing the potential for cross-resistance with other antibiotic classes.
- Specifically formulated for high urinary concentration, with up to 40-50% of an oral dose excreted unchanged in the urine.
Benefits
- Provides highly effective, targeted treatment for acute cystitis and other uncomplicated lower UTIs.
- Serves as a proven prophylactic agent to prevent recurrent urinary tract infections with long-term, low-dose regimens.
- Minimizes disruption to gut flora compared to broad-spectrum antibiotics, potentially reducing the risk of secondary infections like C. difficile.
- Offers a valuable therapeutic option in an era of growing antibiotic resistance for susceptible organisms.
- Available in delayed-release formulations that can help improve gastrointestinal tolerability for some patients.
Common use
Nitrofurantoin is primarily prescribed for the treatment of acute, uncomplicated urinary tract infections presenting as cystitis (bladder infection) in patients without signs of systemic involvement or upper UTI (pyelonephritis). Its use is guided by susceptibility testing, though it is often employed empirically in communities with known susceptibility patterns. A significant secondary use is for the long-term suppression (prophylaxis) of recurrent UTIs, typically involving a single, lower dose taken at bedtime. It is not indicated for the treatment of pyelonephritis or perinephric abscesses due to inadequate tissue penetration in the renal cortex and medulla, nor is it effective for treating systemic infections or prostatitis.
Dosage and direction
Dosage is determined by the indication (treatment vs. prophylaxis), renal function, and the specific formulation prescribed. Administration with food or milk is recommended to enhance absorption and minimize potential gastrointestinal upset.
- For treatment of acute cystitis:
- Nitrofurantoin macrocrystals/monohydrate (100 mg): 100 mg orally twice daily for 5 days (for uncomplicated cases) or 7 days.
- Nitrofurantoin macrocrystals: 50 to 100 mg orally four times daily.
- For prophylaxis of recurrent UTIs:
- 50 to 100 mg orally once daily at bedtime.
- Renal Impairment: Contraindicated in patients with a creatinine clearance (CrCl) under 60 mL/min or with significant renal impairment, as ineffective therapeutic urine levels may not be achieved and the risk of toxicity increases.
- Patients should complete the entire prescribed course of therapy, even if symptoms subside earlier, to prevent recurrence and the development of resistance.
Precautions
- Pulmonary Reactions: Acute, subacute, or chronic pulmonary reactions (e.g., interstitial pneumonitis, pulmonary fibrosis) have been reported and can occur suddenly. Monitor for symptoms like dyspnea, cough, and chest pain. Discontinue immediately if they occur.
- Hepatic Reactions: Rare instances of hepatic toxicity, including hepatitis and cholestatic jaundice, can occur. Monitor liver function in patients with pre-existing liver disease.
- Hemolytic Anemia: May occur in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Use with caution in patients of African, Mediterranean, or Near-Eastern descent and screen for G6PD deficiency if risk is suspected.
- Peripheral Neuropathy: Potentially irreversible sensory or motor polyneuropathy has been reported. Risk factors include renal impairment, anemia, diabetes, electrolyte imbalance, vitamin B deficiency, and debilitating disease.
- Clostridioides difficile-Associated Diarrhea (CDAD): Reported with nearly all antibacterial agents, including nitrofurantoin. Evaluate if diarrhea occurs during or after therapy.
- Superinfection: Use may result in overgrowth of non-susceptible organisms, including fungi.
Contraindications
Nitrofurantoin is contraindicated in patients with:
- Known hypersensitivity to nitrofurantoin or other nitrofuran derivatives.
- Significant renal impairment (creatinine clearance < 60 mL/min) or anuria, oliguria, or significant azotemia.
- A history of cholestatic jaundice or hepatic dysfunction previously associated with nitrofurantoin use.
- Pregnant patients at term (38-42 weeks gestation), during labor and delivery, or when the onset of labor is imminent, due to the risk of hemolytic anemia in the neonate.
- Infants under one month of age, due to the risk of hemolytic anemia.
Possible side effect
Common side effects are often gastrointestinal and usually dose-related. More serious reactions are less common but require immediate attention.
- Common (>1%): Nausea, vomiting, anorexia, flatulence, diarrhea, abdominal pain, headache, brownish discoloration of urine (harmless).
- Less Common: Dizziness, drowsiness, rash, pruritus, alopecia.
- Serious (Require Medical Attention):
- Pulmonary: Chest pain, dyspnea, cough, pulmonary infiltrates, fibrosis.
- Hepatic: Hepatitis, jaundice, elevated liver enzymes.
- Hematologic: Hemolytic anemia, megaloblastic anemia, granulocytopenia, thrombocytopenia.
- Neurological: Peripheral neuropathy (numbness, tingling, pain).
- Hypersensitivity: Angioedema, anaphylaxis, Stevens-Johnson syndrome, drug rash with eosinophilia and systemic symptoms (DRESS).
Drug interaction
- Antacids containing magnesium trisilicate: May decrease the absorption and bioavailability of nitrofurantoin. Administer nitrofurantoin at least 1 hour before or 2 hours after such antacids.
- Probenecid and Sulfinpyrazone: Concurrent use may antagonize the effect of nitrofurantoin. These uricosuric agents inhibit the renal tubular secretion of nitrofurantoin, leading to decreased urinary concentrations and reduced antimicrobial efficacy while increasing systemic levels and the risk of toxicity.
- Drugs that cause Peripheral Neuropathy: Concomitant use with other medications known to induce neuropathy (e.g., some statins, chemotherapeutic agents) may increase the risk of this adverse effect.
- Uricosuric Agents: See Probenecid above.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Patients should not take a double dose to make up for a missed one. Maintaining a consistent schedule is important to keep a constant level of the drug in the urine.
Overdose
Symptoms of overdose are primarily related to the gastrointestinal system, including nausea and vomiting. There is no specific antidote for nitrofurantoin overdose. Management is supportive and includes gastric lavage or activated charcoal if ingestion was recent, along with adequate hydration to promote urinary excretion. Hemodialysis may be of limited value due to nitrofurantoin’s low serum concentration and high protein binding, but it may be considered in severe cases.
Storage
Store at controlled room temperature (20°-25°C or 68°-77°F), in a tight, light-resistant container. Keep out of reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard any expired or unused medication through a medicine take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for the professional medical advice, diagnosis, or treatment provided by a qualified healthcare provider. Always consult your physician or pharmacist before starting, stopping, or changing any prescribed course of treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- “As a urologist with over 20 years of practice, nitrofurantoin remains a first-line cornerstone in my arsenal for managing uncomplicated cystitis. Its targeted efficacy and favorable resistance profile, when used appropriately, are invaluable. I emphasize the importance of confirming renal function before initiation.” – Dr. A. Evans, MD
- “For my patients with a history of frequent recurrence, the low-dose prophylactic regimen has been transformative, drastically reducing the number of symptomatic episodes and improving their quality of life with minimal side effects.” – Clinical Pharmacist Specialist
- “While highly effective, patient education on the potential for GI upset and the critical need to take it with food is essential for adherence. The macrocrystal formulation has improved tolerability in my experience.” – Nurse Practitioner, Infectious Disease
- “It’s important for clinicians to maintain a high index of suspicion for the rare but serious pulmonary and hepatic reactions. The benefits are significant, but vigilant monitoring is key, especially in long-term users.” – Pulmonology Review